Happy Birthday to us!

Article

This month we are celebrating our first birthday. This time last year we launched the first issue of Ophthalmology Times Europe. I cannot believe it's come round so quickly. Although, when I reflect on how much has been achieved in such a short space of time, I suppose it's surprising that it has only been a year.

This time last year, I was apprehensive. We were about to launch a magazine into the European ophthalmic market and I really wasn't sure how it would be received. It appears that my fears were unnecessary. From the first issue and throughout our first year, we have received such kind comments from many of you and, for that, I would like to thank you so very much. The support that we have received from both doctors and industry figures has been overwhelming. That's not to say that we have rested on our laurels. Over the course of the year, Ophthalmology Times Europe has been listening to what our readers have to say. We have always questioned what it is that you like and what you don't like and the magazine has been constantly evolving to reflect our readers' interests. We will continue to do this in the hope that Ophthalmology Times Europe will, if it hasn't already, become your publication of choice for the latest information and developments that matter to you.

On behalf of the Ophthalmology Times Europe team, I would like to offer you my heartfelt thanks for a wonderful first year. During my time as Editor, I have had the opportunity to meet some wonderful people and work with people from all walks of life. It truly has been an incredible experience so far and I am looking forward to the many birthdays to come.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
© 2025 MJH Life Sciences

All rights reserved.